GUGGENHEIM CAPITAL LLC - CELL THERAPEUTICS INC ownership

CELL THERAPEUTICS INC's ticker is CTIC and the CUSIP is 150934883. A total of 75 filers reported holding CELL THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 34.89 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CELL THERAPEUTICS INC
ValueSharesWeighting
Q1 2014$266,000
+114.5%
78,045
+20.6%
0.00%
Q4 2013$124,000
+21.6%
64,710
+4.1%
0.00%
Q3 2013$102,000
+78.9%
62,173
+15.1%
0.00%
Q2 2013$57,00054,0260.00%
Other shareholders
CELL THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Perceptive Advisors 3,715,000$7,133,0000.86%
OXFORD ASSET MANAGEMENT LLP 1,713,861$3,291,0000.08%
First Heartland Consultants, Inc. 74,624$143,0000.08%
WASHINGTON TRUST Co 346,616$662,0000.05%
Geduld E E 50,000$96,0000.05%
Tradeworx Inc. 37,991$73,0000.03%
Crosspoint Capital Strategies, LLC 25,000$95,0000.03%
Jane Street Holding, LLC 619,120$1,183,0000.02%
UNITED CAPITAL FINANCIAL ADVISORS, LLC 132,236$253,0000.01%
Investors Capital Advisory Services 17,250$32,0000.01%
View complete list of CELL THERAPEUTICS INC shareholders